Get started
Author

Jane Merlevede

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
2016 · Jane Merlevede, Nathalie Droin, et al. · Nature Communications · 219
PDF
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies
2015 · Joseph Saliba, Cécile Saint-Martin, et al. · Nature Genetics · 137
PDF
TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2019 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al. · Clinical Cancer Research · 135
Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas, H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location
2018 · David Castel, Cathy Philippe, et al. · Acta Neuropathologica Communications · 132
PDF
Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
2013 · O Kosmider, R Itzykson, et al. · Leukemia · 45
A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival
2019 · Claudia Silva-Evangelista, Emilie Barret, et al. · Oncogene · 17
BIODICA: a computational environment for Independent Component Analysis of omics data
2022 · Nicolas Captier, Jane Merlevede, et al. · Bioinformatics · 10
PDF
Glioma oncogenesis in the Constitutional mismatch repair deficiency (CMMRD) syndrome
2024 · Lea Guerrini-Rousseau, Jane Merlevede, et al. · Neuro-Oncology Advances · 9
DECONbench: a benchmarking platform dedicated to deconvolution methods for tumor heterogeneity quantification
2021 · Clémentine Decamps, Alexis Arnaud, et al. · BMC Bioinformatics · 6
PDF
Systems Biology Analysis for Ewing Sarcoma
2020 · Marianyela Petrizzelli, Jane Merlevede, et al. · Methods in molecular biology · 3
Depletion of the Long Non-Coding RNA MALAT1 primes Chronic Myelomonocytic Leukemia (CMML) for Differentiation Therapy with All-Trans retinoic Acid (ATRA) through the Transcription Factor CREB
2019 · Maria E Balasis, Alexis Vedder, et al. · Blood · 2
Hgg-42. Glioma Oncogenesis in Constitutionnal Mismatch Repair Deficiency (cmmrd) Syndrome: a Clinico-pathological and Molecular Study in 15 Patients
2018 · Jane Merlevede, Felipe Andreiuolo, et al. · Neuro-Oncology · 1
Neoadjuvant PD-L1/TGFβ Blockade Can Rapidly Disrupt the Tumor Stroma in Head and Neck Cancer Patients
2026 · Caroline Hoffmann, Jan-Timon Werle, et al.
Comprehensive characterization of early-stage Non-Small Cell Lung cancers with multi-modal data integration
2025 · Daniel Schulz, Marie Morfouace, et al. · medRxiv
PDF
186P Post-anti-PD1 tumor characterization of HPV-negative R/M SCCHN: An EORTC IMMUcan sub-project
2023 · A. Van Der Elst, D. Herrero Saboya, et al. · Immuno-Oncology Technology
PDF
1P Integrated data analysis within IMMUcan identifies prognostic features of early NSCLC
2023 · D. Schulz, M. Morfouace, et al. · Immuno-Oncology Technology
PDF
Supplementary Tables from TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2023 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al.
Supplementary Figures from TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2023 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al.
Supplementary Figure Legends from TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2023 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al.
Data from TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2023 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al.
Data from TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2023 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al.
Supplementary Figures from TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2023 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al.
PDF
Supplementary Tables from TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2023 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al.
Supplementary Figure Legends from TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
2023 · Coralie Werbrouck, Cláudia C.S. Evangelista, et al.
HGG-41. Glioma oncogenesis in the constitutional mismatch repair deficiency (CMMRD) syndrome
2022 · Lea Guerrini-Rousseau, Jane Merlevede, et al. · Neuro-Oncology
Works count: 43
Citation count: 715
H-index: 8
I10-index: 7
Year
Topic
Type